GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SenzaGen AB (OSTO:SENZA) » Definitions » ROE % Adjusted to Book Value

SenzaGen AB (OSTO:SENZA) ROE % Adjusted to Book Value : -4.28% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is SenzaGen AB ROE % Adjusted to Book Value?

SenzaGen AB's ROE % for the quarter that ended in Sep. 2024 was -10.39%. SenzaGen AB's PB Ratio for the quarter that ended in Sep. 2024 was 2.43. SenzaGen AB's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -4.28%.


SenzaGen AB ROE % Adjusted to Book Value Historical Data

The historical data trend for SenzaGen AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SenzaGen AB ROE % Adjusted to Book Value Chart

SenzaGen AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only -15.37 -8.63 -13.19 -7.67 -10.80

SenzaGen AB Quarterly Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -11.09 -7.47 -17.04 -4.28

Competitive Comparison of SenzaGen AB's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, SenzaGen AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SenzaGen AB's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SenzaGen AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where SenzaGen AB's ROE % Adjusted to Book Value falls into.



SenzaGen AB ROE % Adjusted to Book Value Calculation

SenzaGen AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-28.09% / 2.60
=-10.80%

SenzaGen AB's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-10.39% / 2.43
=-4.28%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SenzaGen AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of SenzaGen AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


SenzaGen AB Business Description

Traded in Other Exchanges
N/A
Address
Scheeletorget 1, Medicon Village, Building 401, Lund, SWE, 223 81
SenzaGen AB markets sells, and performs the in vitro Genomic Allergen Rapid Detection (GARD) sensitization test through its laboratory and licensed Contract Research Organizations (CROs) in Sweden. It offers animal-free testing of chemical compounds in cosmetics, pharmaceuticals, food products, and dyes. It operates in five market segments- Cosmetics, Chemicals, Medical devices, Pharmaceuticals, and Nutrition/food additives. The majority is from the Pharmaceuticals segment. Geographically it operates in North America, Europe, APAC, and RoW, the majority is from Europe.

SenzaGen AB Headlines

No Headlines